EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lignin as a Bioactive Additive in Chlorzoxazone-Loaded Pharmaceutical Tablets

Andreea Creteanu, Gabriela Lisa iD, Cornelia Vasile iD, Maria-Cristina Popescu iD, Daniela Pamfil, Alina-Diana Panainte iD, Gladiola Tantaru, Madalina-Alexandra Vlad, Claudiu N Lungu iD

Molecules · 23.03.2025 · 30 (7) · 1426

DOI: 10.3390/molecules30071426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 23.03.2025. Verfasst von Andreea Creteanu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iaș…. Hauptthemen laut MEDLINE: Chlorzoxazone, Lignin, Excipients, Drug Liberation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the present work, the application of lignin (LIG) as a bioactive additive for the preparation of drug-loaded tablets by direct compression has been studied, and its influence on the release of chlorzoxazone (CLZ) from the hydrophilic matrices has been followed. In hydrophilic matrices, the excipients Kollidon® SR (KOL) and chitosan (CHT) have been used in various amounts and tested in the preparation of 500 mg tablets. They were used as matrix-forming agents, and their influence on the flow and the compressibility properties as well as their effect on the pharmaco-chemical characteristics of the matrix tablets have been studied. Based on the initial evaluation of the pharmaco-technical analysis, pharmaco-chemical characteristics, and in vitro release profile, three matrix tablet formulations (FLa, FLb, and FLc) were selected and further tested. They were evaluated through Fourier-transform infrared spectrometry (FTIR), X-ray diffraction (XRD), thermogravimetry (TG), differential scanning calorimetry (DSC), and in vitro dissolution tests. The three formulations were comparatively studied regarding the release kinetics of active substances using in vitro release testing. The in vitro kinetic study reveals a complex release mechanism occurring in two steps of drug release. The first one is a burst effect that occurs within the first 0–2 h, involving a rapid release of the majority of the drug in a short time, followed by the second step as a prolonged release of the drug, which is relatively constant with a fixed rate over the next 2–36 h. Two factors have been calculated to assess the release profile of chlorzoxazone: f1—the similarity factor and f2—the difference factor together with the correlation coefficient R2. Comparing their values, the three optimal formulations have been selected, containing 55 mg LIG (FLa), 60 mg LIG (FLb), or 65 mg LIG (FLc), confirming that LIG next to KOL and CHT influenced the release characteristics of the matrix tablets. Due to the presence of lignin in the matrix of the three formulations, FLa, FLb, and FLc tablets with CLZ, the antioxidant activity has improved. The antioxidant activity of FLc was found to be 21.36% ± 1.06 greater than that of FLa and FLb. The tablets FLa, FLb, and FLc also presented higher antimicrobial activity against Staphylococcus aureus, Escherichia coli, Candida albicans, and colistin-resistant Klebsiella spp. The higher the concentration of LIG in the matrix (FLc), the higher the antimicrobial activity. By using LIG, the drug dose could be decreased. It can be concluded that lignin can be used as a multifunctional pharmaceutical bioactive additive/excipient for tablets. Its interesting properties have been proven, and its use as a pharmaceutical active additive should be exploited for different applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorzoxazoneLigninExcipientsDrug LiberationAnti-Infective AgentsAntioxidantsTabletsPhytochemicalsPovidoneChitosanSpectroscopy, Fourier Transform InfraredX-Ray DiffractionStaphylococcus aureusEscherichia coliCandida albicansKlebsiella

Stichwörter der Autor:innen

antimicrobial propertiesantioxidantchlorzoxazoneligninmatrix tablets

Substanzen

ChlorzoxazoneTabletsLigninPhytochemicalsPovidoneExcipientsChitosanAnti-Infective AgentsAntioxidants

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
  • Department of Chemical Engineering, Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University, 73 Prof. Dimitrie Mangeron, Street, 700050 Iași, Romania.
  • Physical Chemistry of Polymers Department, Petru Poni Institute of Macromolecular Chemistry, 41A Gr. Ghica Voda Alley, 700487 Iași, Romania.
  • Department of Analytical Chemistry, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
  • Department of Microbiology, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iași, Romania.
  • Department of Functional and Morphological Science, Faculty of Medicine and Pharmacy, Dunarea de Jos University, 800008 Galati, Romania.

ORCID-Profile: Gabriela Lisa, Cornelia Vasile, Maria-Cristina Popescu, Alina-Diana Panainte, Claudiu N Lungu

Zitieren

APA

Creteanu, A., Lisa, G., Vasile, C., Popescu, M. C., Pamfil, D., Panainte, A. D., Tantaru, G., Vlad, M. A., & Lungu, C. N. (2025). Lignin as a Bioactive Additive in Chlorzoxazone-Loaded Pharmaceutical Tablets. Molecules, 30(7), 1426. https://doi.org/10.3390/molecules30071426

Vancouver

Creteanu A, Lisa G, Vasile C, Popescu MC, Pamfil D, Panainte AD, et al. Lignin as a Bioactive Additive in Chlorzoxazone-Loaded Pharmaceutical Tablets. Molecules. 2025;30(7):1426. doi:10.3390/molecules30071426

BibTeX
@article{Creteanu2025,
  author = {Creteanu, Andreea and Lisa, Gabriela and Vasile, Cornelia and Popescu, Maria-Cristina and Pamfil, Daniela and Panainte, Alina-Diana and Tantaru, Gladiola and Vlad, Madalina-Alexandra and Lungu, Claudiu N},
  title = {Lignin as a Bioactive Additive in Chlorzoxazone-Loaded Pharmaceutical Tablets},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {7},
  pages = {1426},
  doi = {10.3390/molecules30071426}
}
Kostenlos starten →